Cite
Netherton syndrome: Temporary response to dupilumab.
MLA
Aktas, Meryem, et al. “Netherton Syndrome: Temporary Response to Dupilumab.” Pediatric Dermatology, vol. 37, no. 6, Nov. 2020, pp. 1210–11. EBSCOhost, https://doi.org/10.1111/pde.14362.
APA
Aktas, M., Salman, A., Apti Sengun, O., Comert Ozer, E., Hosgoren Tekin, S., Akin Cakici, O., Demir, G., & Ergun, T. (2020). Netherton syndrome: Temporary response to dupilumab. Pediatric Dermatology, 37(6), 1210–1211. https://doi.org/10.1111/pde.14362
Chicago
Aktas, Meryem, Andac Salman, Ozlem Apti Sengun, Elif Comert Ozer, Selcen Hosgoren Tekin, Ozlem Akin Cakici, Gizem Demir, and Tulin Ergun. 2020. “Netherton Syndrome: Temporary Response to Dupilumab.” Pediatric Dermatology 37 (6): 1210–11. doi:10.1111/pde.14362.